125 related articles for article (PubMed ID: 24154619)
1. The antioxidant activity of daidzein metabolites, O‑desmethylangolensin and equol, in HepG2 cells.
Choi EJ; Kim GH
Mol Med Rep; 2014 Jan; 9(1):328-32. PubMed ID: 24154619
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.
Reverri EJ; Slupsky CM; Mishchuk DO; Steinberg FM
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27364093
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.
Jackman KA; Woodman OL; Chrissobolis S; Sobey CG
Brain Res; 2007 Apr; 1141():99-107. PubMed ID: 17274967
[TBL] [Abstract][Full Text] [Related]
6. The intracellular metabolism of isoflavones in endothelial cells.
Toro-Funes N; Morales-Gutiérrez FJ; Veciana-Nogués MT; Vidal-Carou MC; Spencer JP; Rodriguez-Mateos A
Food Funct; 2015 Jan; 6(1):98-108. PubMed ID: 25410768
[TBL] [Abstract][Full Text] [Related]
7. Lactulose increases equol production and improves liver antioxidant status in barrows treated with Daidzein.
Zheng W; Hou Y; Yao W
PLoS One; 2014; 9(3):e93163. PubMed ID: 24667812
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of catalase in human hepatoma cells by the soy isoflavone, daidzein.
Kampkötter A; Wiegand C; Timpel C; Röhrdanz E; Chovolou Y; Kahl R; Wätjen W
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):437-42. PubMed ID: 18047476
[TBL] [Abstract][Full Text] [Related]
9. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States.
Atkinson C; Newton KM; Bowles EJ; Yong M; Lampe JW
Am J Clin Nutr; 2008 Mar; 87(3):679-87. PubMed ID: 18326607
[TBL] [Abstract][Full Text] [Related]
10. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains.
Raimondi S; Roncaglia L; De Lucia M; Amaretti A; Leonardi A; Pagnoni UM; Rossi M
Appl Microbiol Biotechnol; 2009 Jan; 81(5):943-50. PubMed ID: 18820905
[TBL] [Abstract][Full Text] [Related]
11. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
[TBL] [Abstract][Full Text] [Related]
12. Relative Inhibitions of 5-Lipoxygenase and Myeloperoxidase and Free-Radical Scavenging Activities of Daidzein, Dihydrodaidzein, and Equol.
Tsen SY; Tan XY; Tan YM; Yan BY; Loke WM
J Med Food; 2016 Jun; 19(6):543-8. PubMed ID: 27027338
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of equol function on anti- or prooxidant status in vivo.
Choi EJ
J Food Sci; 2009 Mar; 74(2):H65-71. PubMed ID: 19323753
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant effect of a phytoestrogen equol on cultured muscle cells of embryonic broilers.
Wei XJ; Wu J; Ni YD; Lu LZ; Zhao RQ
In Vitro Cell Dev Biol Anim; 2011 Dec; 47(10):735-41. PubMed ID: 22083625
[TBL] [Abstract][Full Text] [Related]
15. Studies on the antioxidant properties of some phytoestrogens.
Kładna A; Berczyński P; Kruk I; Piechowska T; Aboul-Enein HY
Luminescence; 2016 Sep; 31(6):1201-6. PubMed ID: 26799817
[TBL] [Abstract][Full Text] [Related]
16. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production.
Atkinson C; Berman S; Humbert O; Lampe JW
J Nutr; 2004 Mar; 134(3):596-9. PubMed ID: 14988453
[TBL] [Abstract][Full Text] [Related]
17. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.
Atkinson C; Newton KM; Aiello Bowles EJ; Lehman CD; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
Breast Cancer Res Treat; 2009 Aug; 116(3):587-94. PubMed ID: 18821061
[TBL] [Abstract][Full Text] [Related]
18. The phytoestrogen daidzein affects the antioxidant enzyme system of rat hepatoma H4IIE cells.
Röhrdanz E; Ohler S; Tran-Thi QH; Kahl R
J Nutr; 2002 Mar; 132(3):370-5. PubMed ID: 11880557
[TBL] [Abstract][Full Text] [Related]
19. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.
Jackman KA; Woodman OL; Sobey CG
Curr Med Chem; 2007; 14(26):2824-30. PubMed ID: 18045128
[TBL] [Abstract][Full Text] [Related]
20. Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine.
Minamida K; Tanaka M; Abe A; Sone T; Tomita F; Hara H; Asano K
J Biosci Bioeng; 2006 Sep; 102(3):247-50. PubMed ID: 17046543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
